To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Dr. Alveda King: Happy New Year, Happy Birthday Uncle

Florida Joins Texas in Ending American Bar Association's 'Gatekeeper' Grip on Law Schools

Another Victory for Tom Fitton and Judicial Watch; Oregon Agrees to Clean 800,000 Names of Inactive Voters from Voter Rolls

Nick Shirley Drops Another Bombshell Video, Exposing Even More Fraud [Videos]

DHS: NY Times' 'Despicably Misleading Headline' Is Why Media Aren't Trusted

Hyde Amendment Absent from Trump Health Plan, but White House Promises 'Strongest Possible Pro-Life Protections'

Alaska Finally Complies With Federal Law Defunding Planned Parenthood from Medicaid

US Armada Nears Middle East amid Heartbreaking Stories from Iran: 'They're Shooting Their Children'

President Trump Receives an Historic Gift from Venezuela's Opposition Leader

Election Integrity Win: SCOTUS Greenlights Lawsuits against Late Mail-In Ballots; Opens Door to Nationwide Challenges

VP Vance's Tie-Breaking Vote Tanks Resolution Restricting Venezuela Military Actions

House Republicans Have Enough Votes to Hold Clintons in Contempt of Congress, Comer Reveals

Abortion 'Doctor' Won't Answer Congress on Whether Men Can Get Pregnant

Federal DHS Employee Doxxes Identities of Thousands of ICE and Border Patrol Agents and the Search Is ON

Father-in-Law of Renee Good Refuses to Blame ICE, Urges Americans to Turn to God

Prayer Alert: Rioters Smash into ICE Vehicles; Minneapolis Police Stand Down—Report

President Trump Threatens Invoking Insurrection Act as Minnesota Rioting Escalates, Endangering Federal Officers

Pentagon Moves Carrier Strike Group Toward Middle East as Iran Death Reports 'Incredibly Dire'

'Dilbert' Creator Scott Adams Dies at Age 68

Ambassador Huckabee Predicts a 'Complete Realignment of the Middle East' [VIDEO]

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor